Murat Ozbalak
Istanbul, 34093, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
IDH1 Mutations in Acute Myeloid Leukemia: Frequency and Clinical Features in the Context of FLT3 and NPM1 Co-Mutations-A Single-Center Study from Turkey.
Journal: Current issues in molecular biology
Published: July 05, 2026
Novel prognostic factor in thrombotic thrombocytopenic purpura: human leukocyte antigen class II.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Published: April 15, 2025
Simplified Molecular International Prognostic Index as an eligibility criterion for clinical trials: Analysis of the Turkish Lymphoma Study Group's large B-cell lymphoma cohort.
Journal: British journal of haematology
Published: January 29, 2025
Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV. A retrospective analysis of the EBMT Lymphoma Working Party in collaboration with GELTAMO, FIL, LYSA, and Turkish Lymphoma Group.
Journal: Bone marrow transplantation
Published: November 28, 2024
The Effect of T-Lymphocyte Subgroups at Diagnosis on the Prognosis of Chronic Lymphocytic Leukemia.
Journal: Acta haematologica
Published: March 25, 2024
Sequencing novel agents in the treatment of classical Hodgkin lymphoma.
Journal: Expert review of hematology
Published: October 28, 2023
Independent risk factors for COVID-19-associated coagulopathy.
Journal: European review for medical and pharmacological sciences
Published: September 05, 2023
Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data.
Journal: Hematological oncology
Published: October 25, 2022
Treatment of Mantle-Cell Lymphoma.
Journal: The New England journal of medicine
Published: September 21, 2022
Central nervous system involvement of mantle cell lymphoma: Case report and review of the literature.
Journal: Hematology, transfusion and cell therapy
Published: July 17, 2022
Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: June 03, 2022
Dipyridamole does not have any additive effect on the prevention of COVID-19 coagulopathy.
Journal: American journal of blood research
Published: January 10, 2022
Last Updated: 09/26/2026